COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,646 Articles (22,913 medRxiv, 8,733 bioRxiv)

Most recent first Previous |  Page 2887: Articles 28861-28870  | Next

A Susceptible-Infected-Removed (SIR) model of COVID-19 epidemic trend in Malaysia under Movement Control Order (MCO) using a data fitting approach
Arifin, W. N., Chan, W. H., Amaran, S., Musa, K. I.
10.1101/2020.05.01.20084384 — Posted: 2020-05-05 Discussion: Onsite
A novel deterministic forecast model for COVID-19 epidemic based on a single ordinary integro-differential equation
Koehler-Rieper, F., Roehl, C. H. F., De Micheli, E.
10.1101/2020.04.29.20084376 — Posted: 2020-05-05
Epidemic Models for Personalised COVID-19 Isolation and Exit Policies Using Clinical Risk Predictions
Evgeniou, T., Fekom, M., Ovchinnikov, A., Porcher, R., Pouchol, C., Vayatis, N.
10.1101/2020.04.29.20084707 — Posted: 2020-05-05
Suppress, and not just flatten:Strategies for Rapid Suppression of COVID19 transmission in Small World Communities
Bhattacharyya, C., Vinay, V.
10.1101/2020.04.29.20085126 — Posted: 2020-05-05
Mathematical model describing CoViD-19 in Sao Paulo State, Brazil - Evaluating isolation as control mechanism and forecasting epidemiological scenarios of release
Yang, H. M., Lombardi Junior, L. P., Castro, F. F. M., Yang, A. C.
10.1101/2020.04.29.20084830 — Posted: 2020-05-05
COVID-19: How to Relax Social Distancing If You Must
Duque, D., Morton, D. P., Singh, B., Du, Z., Pasco, R., Meyers, L. A.
10.1101/2020.04.29.20085134 — Posted: 2020-05-05
Agent-Level Pandemic Simulation (ALPS) for Analyzing Effects of Lockdown Measures
Srivastava, A.
10.1101/2020.04.29.20084699 — Posted: 2020-05-05
Vitamin D status, body mass index, ethnicity and COVID-19: Initial analysis of the first-reported UK Biobank COVID-19 positive cases (n 580) compared with negative controls (n 723)
Darling, A. L., Ahmadi, K. R., Ward, K. A., Harvey, N. C., Couto Alves, A., Dunn-Waters, D. K., Lanham-New, S. A., Cooper, C., Blackbourn, D. J.
10.1101/2020.04.29.20084277 — Posted: 2020-05-05 Discussion: Onsite
COVID-19 length of hospital stay: a systematic review and data synthesis
Rees, E. M., Nightingale, E. S., Jafari, Y., Waterlow, N., Clifford, S., CMMID Working Group, , Jombert, T., Procter, S. R., Knight, G. M.
10.1101/2020.04.30.20084780 — Posted: 2020-05-05
Pre-Existing Characteristics Associated with Covid-19 Illness Severity
Ebinger, J. E., Achamallah, N., Ji, H., Claggett, B. L., Sun, N., Botting, P., Nguyen, T.-T., Luong, E., Kim, E. H., Park, E., Liu, Y., Rosenberry, R., Matusov, Y., Zhao, S., Pedraza, I., Zaman, T., Thompson, M., Raedschelders, K., Berg, A. H., Grein, J. D., Noble, P. W., Chugh, S. S., Bairey Merz, C. N., Marban, E., Van Eyk, J. E., Solomon, S. D., Albert, C. M., Chen, P., Cheng, S.
10.1101/2020.04.29.20084533 — Posted: 2020-05-05 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).